Cerebrospinal fluid interleukin-6 in progressive neuro-Behcet's syndrome

Clinical Immunology and Immunopathology

Volumn 82, Issue 1, 1997, Pages 12-17

  Hirohata, Shunsei ^a   Isshi, Kunio ^a   Oguchi, Hiroko ^a   Ohse, Toru ^a   Haraoka, Hitomi ^a   Takeuchi, Akiteru ^a   Hashimoto, Takashi ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; BEHCET DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0031033358     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.4268     Document Type: Article

References (14)

1. 1. O'Duffy, J. D., and Goldstein, N. P., Neurologic involvement in seven patients with Behçet's disease. Am. J. Med. 61, 170-178, 1976.
2. 2. Inaba, G., Behcet's disease. In "Handbook of Clinical Neurology" (R. R. McKendall, Ed.), Vol. 12, pp. 539-610, Elsevier, Amsterdam, 1989.
3. 3. Houssiau, F. A., Bukasa, K., Sindic, C. J. M., Van Damme, J., and Van Snick, J., Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin. Exp. Immunol. 71, 320-323, 1988.
4. 4. Hirohata, S., and Miyamoto, T., Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous involvement. Arthritis Rheum. 33, 644-649, 1990.
5. 5. Hirohata, S., Takeuchi, A., and Miyamoto, T., Elevated levels of interleukin 6 in cerebrospinal fluid from patients with neuro-Behcet's syndrome. In "Behcet's Disease" (J. D. O'Duffy and E. Kokmen, Eds.), pp. 369-376, Dekker, New York, 1991.
6. 6. Tibbling, G., Link, H., and Ohman, S., Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand. J. Clin. Lab. Invest. 37, 385-390, 1977.
7. 7. Hirohata, S., Kamoshita, H., and Taketani, T., Blood-brain barrier function and intrathecal immunoglobulin synthesis in various neurological diseases. J. Transp. Med. 40, 71-75, 1986.
8. 8. Hirohata, S., Kamoshita, H., and Taketani, T., Spontaneous remission of meningoencephalitis in Behcet's disease. J. Rheumatol. 16, 1283-1284, 1989.
9. 9. Matsuda, T., Hirano, T., and Kishimoto, T., Establishment of interleukin 6 (IL6)/B cell stimulatory factor 2 (BSF-2)-dependent cell line and preparation of anti-IL6/BSF-2 monoclonal antibodies. Eur. J. Immunol. 18, 951-956, 1988.
10. 10. Hirohata, S., Tanimoto, K., and Ito, K., Elevation of cerebrospinal fluid interleukin-6 activity in patients with vasculitides and central nervous system involvement. Clin. Immunol. Immunopathol. 66, 225-229, 1993.
11. 11. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63, 1983.
12. 12. Hirohata, S., Takeuchi, A., and Miyamoto, T., Association of cerebrospinal fluid IgM index with central nervous system involvement in Behçet's disease. Arthritis Rheum. 28, 793-796, 1986.
13. 13. Terada, T., Ose, T., Haraoka, H., Hirohata, S., Takeuchi, A., and Hashimoto, T., Magnetic resonance imaging in neuro-Behçet's disease. Arthritis Rheum. 34(Suppl.), S198, 1991.
14. 14. Nakae, K., Hashimoto, T., Inaba, G., Mochizuki, M., Sakane, T., and Furusawa, F., The 4th nationwide epidemiological surveys on Behcet's disease in Japan: Clinicoepidemiological features. In "Annual Report of the Behcet's Disease Research Committee of Japan," pp. 70-82, 1993. [In Japanese]